PAI
NNVC icon

Pittenger & Anderson Inc’s NanoViricides NNVC Stock Holding History

Pittenger & Anderson Inc’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-15
Closed – – 404
2017
Q3 		$0 Buy
+15
New +$403 ﹤0.01% 389

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PTB
Pioneer Trust Bank Salem, Oregon $441M AUM 21.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

Pittenger & Anderson Inc's NNVC Position: Q4 2017 in Review

Pittenger & Anderson Inc sold out of NanoViricides (NNVC) in Q4 2017, closing a stake of 15 shares.

Pittenger & Anderson Inc first reported a position in NNVC in Q3 2017 and held it in 1 quarter. The position peaked at $0 in Q3 2017. 44 funds tracked by Wall St. Rank hold NNVC as of Q4 2017.

  • Pittenger & Anderson Inc reported no remaining NanoViricides position as of Q4 2017 after selling out during the quarter.
  • Pittenger & Anderson Inc sold 15 NanoViricides shares in Q4 2017.
  • Pittenger & Anderson Inc first reported a position in NanoViricides in Q3 2017 and held it in 1 quarter.
  • Pittenger & Anderson Inc's NanoViricides position peaked at $0 in Q3 2017.
  • 44 funds tracked by Wall St. Rank held NanoViricides as of Q4 2017.

Based on Pittenger & Anderson Inc's 13F filing for Q4 2017, filed 13 Feb 2018.